Moderna
MRNA
#1165
Rank
C$23.01 B
Marketcap
$59.81
Share price
-3.80%
Change (1 day)
-44.52%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: C$23.01 Billion

As of December 2024 Moderna has a market cap of C$23.01 Billion. This makes Moderna the world's 1165th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2024

End of year Market Cap

Year Marketcap Change
2024C$23.01 B-54.24%
2023C$50.29 B-46.29%
2022C$93.63 B-28.65%
2021C$131.23 B148.97%
2020C$52.71 B513.11%
2019C$8.59 B25.71%
2018C$6.83 B

End of Day market cap according to different sources

On Dec 2nd, 2024 the market cap of Moderna was reported to be:

C$24.10 Billion
by Yahoo Finance info icon info icon
C$24.10 Billion
by CompaniesMarketCap info icon info icon
C$23.92 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
C$0.15 B-99.34%๐Ÿ‡บ๐Ÿ‡ธ USA
C$362.02 B 1,472.87%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.17 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
C$45.23 B 96.54%๐Ÿ‡บ๐Ÿ‡ธ USA
C$296.43 B 1,187.92%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
C$4.67 B-79.69%๐Ÿ‡บ๐Ÿ‡ธ USA
C$518.42 B 2,152.38%๐Ÿ‡บ๐Ÿ‡ธ USA
C$4.18 B-81.83%๐Ÿ‡บ๐Ÿ‡ธ USA